Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Genes (Basel) ; 12(11)2021 10 21.
Article in English | MEDLINE | ID: mdl-34828264

ABSTRACT

The Plasmodium vivax Cysteine-Rich Protective Antigen (PvCyRPA) has an important role in erythrocyte invasion and has been considered a target for vivax malaria vaccine development. Nonetheless, its genetic diversity remains uncharted in Brazilian malaria-endemic areas. Therefore, we investigated the pvcyrpa genetic polymorphism in 98 field isolates from the Brazilian Amazon and its impact on the antigenicity of predicted B-cell epitopes. Genetic diversity parameters, population genetic analysis, neutrality test and the median-joining network were analyzed, and the potential amino acid polymorphism participation in B-cell epitopes was investigated. One synonymous and 26 non-synonymous substitutions defined fifty haplotypes. The nucleotide diversity and Tajima's D values varied across the coding gene. The exon-1 sequence had greater diversity than those of exon-2. Concerning the prediction analysis, seven sequences were predicted as linear B cell epitopes, the majority contained in conformational epitopes. Moreover, important amino acid polymorphism was detected in regions predicted to contain residues participating in B-cell epitopes. Our data suggest that the pvcyrpa gene presents a moderate polymorphism in the studied isolates and such polymorphisms alter amino acid sequences contained in potential B cell epitopes, an important observation considering the antigen potentiality as a vaccine candidate to cover distinct P. vivax endemic areas worldwide.


Subject(s)
Antigens, Protozoan/genetics , Plasmodium vivax/genetics , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Cysteine/chemistry , Cysteine/genetics , Female , Genetic Variation , Genetics, Population , Geography , Humans , Malaria, Vivax/epidemiology , Malaria, Vivax/parasitology , Malaria, Vivax/prevention & control , Male , Middle Aged , Plasmodium vivax/immunology , Plasmodium vivax/isolation & purification , Polymorphism, Genetic , Protozoan Proteins/genetics , Sequence Analysis, DNA , Vaccine Development , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...